Area of research
Infectious Diseases · Genetics
Research interest
Research focused on Mendelian randomization and Odds ratio, with related work in Type 2 diabetes, Monoclonal antibody, Benzimidazole. Notable publications include 'Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study', 'SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody', and 'Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro'.
Genetically proxied inhibition of kidney function pathways and increased risk of type 2 diabetes in Africans: A Mendelian randomization study
KidneyGenAfrica, a pan-African partnership to deliver research and training excellence in genomics of kidney disease
Structural insights into conformational stability of both wild-type and mutant Insulin Receptor Gene
An in-silico analysis of OGT gene association with diabetes mellitus
Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
A Mendelian randomization study of genetic liability to post-traumatic stress disorder and risk of ischemic stroke
Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study
SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody